Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17086911 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: GW-1000-02

Indicates status has not been verified in more than two years